APA vs FGEN · P/E 7.2, $7.26B cap vs rev $29.6M
APA Corporation (APA) versus FibroGen Inc (FGEN) — a side-by-side from cached financials, not a winner call.
APA Corporation (APA) is a oil & gas e&p company listed on US.
FibroGen Inc (FGEN) is a biotechnology company listed on NASDAQ.
APA does not have a complete income-statement cache yet.
Latest reported FGEN revenue for 2024-12-31 was $29.6M. Net income was -$47.6M. Revenue was down 36.7% from 2023-12-31 to 2024-12-31. FGEN currently screens at market cap $39.3M.
APA currently screens at market cap $7.26B and trailing P/E 7.2. FGEN currently screens at market cap $39.3M.
Not investment advice. Open the APA and FGEN stock pages for the full models.
Not investment advice.